Fieldpoint Private Securities’s Edwards Lifesciences EW Stock Holding History

Fieldpoint Private Securities’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$42K	Sell	441 -496	-53%	-$51.3K	0.01%	513
2022 Q1	$110K	Buy	937 +10	+1%	+$1.12K	0.02%	419
2021 Q4	$120K	Buy	927 +428	+86%	+$49.9K	0.02%	406
2021 Q3	$56K	Buy	499 +47	+10%	+$5.37K	0.01%	545
2021 Q2	$51K	Hold	452	–	–	0.01%	567
2021 Q1	$38K	Sell	452 -40	-8%	-$3.38K	0.01%	628
2020 Q4	$45K	Buy	+492	New	+$40.8K	0.01%	491
2020 Q1	–	Sell	-384	Closed	-$30K	–	348
2019 Q4	$30K	Buy	384 +15	+4%	+$1.17K	0.01%	503
2019 Q3	$27K	Buy	369 +69	+23%	+$4.85K	0.01%	477
2019 Q2	$18K	Hold	300	–	–	0.01%	544
2019 Q1	$19K	Hold	300	–	–	0.01%	335
2018 Q4	$15K	Hold	300	–	–	0.01%	340
2018 Q3	$17K	Hold	300	–	–	0.01%	362
2018 Q2	$15K	Hold	300	–	–	0.01%	371
2018 Q1	$14K	Hold	300	–	–	0.01%	368
2017 Q4	$11K	Hold	300	–	–	0.01%	358
2017 Q3	$11K	Buy	+300	New	+$11.4K	﹤0.01%	580

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fieldpoint Private Securities's EW Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Edwards Lifesciences (EW) stake by 53% in Q2 2022, selling an estimated $51.3K and leaving 441 shares worth $42K. The position accounts for 0.01% of the portfolio, ranked #513.

Fieldpoint Private Securities first reported a position in EW in Q3 2017 and has held it in 17 quarters since. The position peaked at $120K in Q4 2021. 1,273 funds tracked by Wall St. Rank hold EW as of Q2 2022.

Fieldpoint Private Securities held 441 shares of Edwards Lifesciences worth $42K as of Q2 2022.
Fieldpoint Private Securities sold 496 Edwards Lifesciences shares in Q2 2022, an estimated $51.3K.
Edwards Lifesciences made up 0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #513 holding.
Fieldpoint Private Securities first reported a position in Edwards Lifesciences in Q3 2017 and has held it in 17 quarters since.
Fieldpoint Private Securities's Edwards Lifesciences position peaked at $120K in Q4 2021.
1,273 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.